Manulife (Manufacturers Life Insurance)’s Terns Pharmaceuticals TERN Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.47M	Sell	46,784 -32,991	-41%	-$1.36M	﹤0.01%	1414
2025 Q4	$3.23M	Buy	79,775 +54,851	+220%	+$1.27M	﹤0.01%	1350
2025 Q3	$187K	Sell	24,924 -2,338	-9%	-$14.9K	﹤0.01%	2605
2025 Q2	$102K	Buy	27,262 +2,097	+8%	+$6.55K	﹤0.01%	2753
2025 Q1	$69.5K	Buy	25,165 +787	+3%	+$3.21K	﹤0.01%	2778
2024 Q4	$135K	Sell	24,378 -41,722	-63%	-$283K	﹤0.01%	2758
2024 Q3	$551K	Buy	66,100 +43,455	+192%	+$358K	﹤0.01%	2238
2024 Q2	$154K	Buy	22,645 +5,049	+29%	+$30.6K	﹤0.01%	2699
2024 Q1	$115K	Sell	17,596 -2,173	-11%	-$14.2K	﹤0.01%	2747
2023 Q4	$128K	Buy	19,769 +2,789	+16%	+$14.7K	﹤0.01%	2750
2023 Q3	$85.4K	Buy	16,980 +144	+0.9%	+$914	﹤0.01%	2855
2023 Q2	$147K	Buy	+16,836	New	+$196K	﹤0.01%	2723

Other funds holding TERN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s TERN Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Terns Pharmaceuticals (TERN) stake by 41% in Q1 2026, selling an estimated $1.36M and leaving 46,784 shares worth $2.47M. The position accounts for ﹤0.01% of the portfolio, ranked #1414.

Manulife (Manufacturers Life Insurance) first reported a position in TERN in Q2 2023 and has held it in 12 quarters since. The position peaked at $3.23M in Q4 2025. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

Manulife (Manufacturers Life Insurance) held 46,784 shares of Terns Pharmaceuticals worth $2.47M as of Q1 2026.
Manulife (Manufacturers Life Insurance) sold 32,991 Terns Pharmaceuticals shares in Q1 2026, an estimated $1.36M.
Terns Pharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1414 holding.
Manulife (Manufacturers Life Insurance) first reported a position in Terns Pharmaceuticals in Q2 2023 and has held it in 12 quarters since.
Manulife (Manufacturers Life Insurance)'s Terns Pharmaceuticals position peaked at $3.23M in Q4 2025.
317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.